Levin Capital Strategies’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-300
Closed -$304K 366
2021
Q2
$304K Buy
+300
New +$263K 0.03% 228

Other funds holding AGL

Levin Capital Strategies's AGL Position: Q3 2021 in Review

Levin Capital Strategies sold out of Agilon Health (AGL) in Q3 2021, closing a stake of 300 shares — an estimated $304K sold.

Levin Capital Strategies first reported a position in AGL in Q2 2021 and held it in 1 quarter. The position peaked at $304K in Q2 2021. 102 funds tracked by Wall St. Rank hold AGL as of Q3 2021.

  • Levin Capital Strategies reported no remaining Agilon Health position as of Q3 2021 after selling out during the quarter.
  • Levin Capital Strategies sold 300 Agilon Health shares in Q3 2021, an estimated $304K.
  • Levin Capital Strategies first reported a position in Agilon Health in Q2 2021 and held it in 1 quarter.
  • Levin Capital Strategies's Agilon Health position peaked at $304K in Q2 2021.
  • 102 funds tracked by Wall St. Rank held Agilon Health as of Q3 2021.

Based on Levin Capital Strategies's 13F filing for Q3 2021, filed 10 Nov 2021.